Epoetin Injection

About Epoetin 5000 IU/.5 ml Injection

The injection Epoetin contains Erythropoietin and is made by Incepta Pharmaceuticals Ltd. It is also used for anemia in some patients with non-myeloid cancers when the anemia is caused by chemotherapy given at the same time.

There are 8 brands of Erythropoietin listed in Bangladesh.

What is Epoetin 5000 IU/.5 ml Injection?

Epoetin comes as a injection with 5000 IU/.5 ml of Erythropoietin, from Incepta Pharmaceuticals Ltd. Because it is given by injection, it is handled by a doctor or a trained health worker. Epoetin injection contains Erythropoietin, a protein that works like a natural hormone the body makes to stimulate red blood cell production. The doctor decides the dose, the route and how often it is given, and monitors the response with blood tests over time.

Uses of Epoetin

It is also used for anemia in some patients with non-myeloid cancers when the anemia is caused by chemotherapy given at the same time. It is not a general tonic for tiredness. Epoetin is used to treat anemia linked to chronic kidney failure, including in people who are on dialysis and those who are not. Ask your doctor whether it is right for your condition.

How to use Epoetin

Epoetin is given as an injection by a doctor or trained healthcare professional, either into a vein or under the skin. Do not inject it yourself unless a doctor has shown you how. Take Epoetin 5000 IU/.5 ml injections exactly as your doctor tells you. The doctor decides the dose, how often it is given, and how long treatment continues, based on blood tests and the patient's response. Complete the course exactly as prescribed.

Side effects of Epoetin

Allergic reactions are possible. Some people feel sick, vomit, lose appetite or have diarrhoea. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Iron levels should be checked before and during treatment. In pregnancy it is used only if clearly needed, and caution is advised during breastfeeding. Epoetin is not for people with uncontrolled high blood pressure, or with a known allergy to mammalian cell-derived products or to Erythropoietin or any ingredient of the preparation. Keep out of reach of children.

Frequently asked questions

What does Epoetin treat?

It is also used for anemia in some patients with non-myeloid cancers when the anemia is caused by chemotherapy given at the same time. It is not a general tonic for tiredness.

How is Epoetin used?

Epoetin is given as an injection by a doctor or trained healthcare professional, either into a vein or under the skin. Do not inject it yourself unless a doctor has shown you how.

What are the side effects of Epoetin?

Allergic reactions are possible. Some people feel sick, vomit, lose appetite or have diarrhoea.

Can I use Epoetin in pregnancy or while breastfeeding?

Iron levels should be checked before and during treatment. In pregnancy it is used only if clearly needed, and caution is advised during breastfeeding.

Indications

Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • ... Read more
Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • Anemic patients (hemoglobin >10 to <13 g/dL) are scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
  • Anemia related to therapy with zidovudine in HIV-infected patients.

Dosage & Administration

Treatment of anemia in chronic renal failure: Erythropoietin is administered to maintain hemoglobin concentration between 11 to 12 g/dl and hematocrit of 33-36 % in adults.

Starting dose:
  • Adult: Usually 50 to 100 lU/kg three times in a week (TIW) by IV or Subcutaneous route.
  • Pediatric: 50 lU/kg TIW by IV or Subcutaneous route.
Dose adjustment: Dose should be increased if hematocrit doses not increase by 5 to 6 points after 8 weeks therapy, and hematocrit is below suggested target range. Dose should be reduced when hematocrit approaches 36% or hematocrit increases >4 points in any 2-week period.

Maintenance dose: Maintenance dose must be individualized for each patient. In patients undergoing dialysis, the median maintenance dose is 75 lU/kg TIW, with a range from 12.5 to 525 lU/kg TIW as directed by the physician. In CRF patients not on dialysis, maintenance dose is 75 to 150 lU/kg/week.

Treatment of Anemia in Cancer Patients on Chemotherapy:

Starting dose:
  • Adult: 150 lU/kg TIW by Subcutaneous route or 40,000 IU Subcutaneous route weekly.
  • Pediatric: 25 to 300 lU/kg 3 to 7 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased to 300 lU/kg TIW. If the hematocrit exceeds 40%, the dose should be withheld until the hematocrit falls to 36%.The dose should be reduced to 25% when treatment is resumed and titrated to maintain the desired hematocrit.

Surgery Patients: The recommended dose is 300 lU/kg/day subcutaneously for 10 days before surgery, on the day of surgery, and for 4 days after surgery. An alternate dose schedule is 600 lU/kg subcutaneously in once weekly dose (21, 14, and 7 days before surgery) plus a fourth dose on the day of surgery.

Zidovudine-treated HIV-infected Patients:
Starting dose
  • Adult: 100 lU/kg as an IV or Subcutaneous injection TIW for 8 weeks.
  • Pediatric: 50 to 400 lU/kg 2 to 3 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased by 50-1001U/kg TIW. Response should be evaluated every 4 to 8 weeks thereafter and the dose adjusted accordingly by 50 to 100 lU/kg increments TIW.

Maintenance dose: The dose is titrated to maintain the hematocrit between 33-36%.

Contraindications

Erythropoietin is contraindicated in patients with:
  • Uncontrolled hypertension
  • Known hypersensitivity to mammalian cell-derived products
  • A history of hypersensitivity to Erythropoietin or any component of the preparation.

Side Effects

General: Headache, dizziness, fever, malaise, arthralgia and occasionally hyperkalemia. Cardiovascular: Hypertension is the most common side effect, palpitations. Gastrointestinal: Nausea, vomiting, anorexia and diarrhea may occur occasionally. Allergic reactions.

Pregnancy & Lactation

Pregnancy Category C. Since there are no controlled studies of erythropoietin in pregnant women, and because animal reproduction studies are not always predictive of human responses, erythropoietin should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when erythropoietin is administered to a nursing woman.

Precautions & Warnings

Erythropoietin should be used with caution in those patients with controlled hypertension, ischaemic vascular disease, history of seizures, or suspected allergy to the product.

Iron evaluation: Prior to and during Erythropoietin therapy, the patient's iron stores, including transferrin saturation and serum ferritin, should be evaluated. Transferrin saturation should be at least 20%, and ferritin should be at least 100 ng/ml. Virtually all patients will require supplemental Iron to increase or maintain transferrin saturation to levels that will adequately support erythropoiesis.

Overdose Effects

Doses of up to 1500 lU/kg TIW for 3 to 4 weeks have been administered to adults without any direct toxic effects. If the suggested target range is exceeded, drug therapy may be temporarily withheld until the hemoglobin returns to the suggested target range. If polycythemia is of concern, phlebotomy may be indicated to decrease the hemoglobin.

Storage Conditions

Erythropoietin should be stored at 2°C to 8°C. Protect from light. Do not freeze & avoid shaking.

Alternative brands of Erythropoietin

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.